.png)
Pharmaceutical research operates on tight timelines. A single day of delay is worth approximately $800,000 in unrealized or lost prescription drug sales and $40,000 in direct daily clinical trial costs. A missed regulatory update or an unnoticed enrollment drop can disrupt an entire program. PharmaXL, the intelligence solution from AppliedXL, provides real-time visibility into clinical developments, ensuring no critical change goes unnoticed.
Real-Time Alerts & AI Briefings for Actionable Decisions
PharmaXL delivers instant notifications on key developments— new research for novel and established drug targets, clinical program shifts, and competitor strategy changes. Alerts are customizable, and each notification includes an AI-generated briefing that distills key takeaways, immediately putting the alert into context for you. Integrated collaboration tools enable seamless information sharing across teams.
Trial Profile Pages & Timelines for Comprehensive Trial Event Tracking
Each trial has a dedicated profile with a timeline capturing major milestones and incremental changes, such as start dates, enrollment updates, and protocol amendments. By mapping trial trajectories, PharmaXL highlights early warning signals that would otherwise take hours of manual effort to detect. Using this capability you can track the evolution of studies and identify early risk signals prior to major disruptions.
Landscape Explorer for a Real-Time Industry Overview
Fragmented data can slow decision-making, but Landscape Explorer streamlines the process by providing a continuously updated view of clinical activity across oncology, immunology, rare diseases, and more. With advanced filters, users can analyze developments by company, target, condition, intervention, and location, gaining a strategic perspective on emerging trends. Built on AppliedXL’s event-driven approach, Landscape Explorer automatically highlights the latest clinical developments, ensuring users can act on the most recent insights.
.png)
Program Pages for Pipeline Visibility and Risk Assessment
Sponsors rarely disclose full program details, making it difficult to track trial relationships. Program Pages consolidate all relevant trials—disclosed and undisclosed—into a single view, clarifying overall progress, identifying risks, and informing resource allocation.
A Smarter Approach to Clinical Intelligence
PharmaXL ensures teams have access to accurate, real-time clinical data. From granular alerts to high-level industry analysis, it enables faster, data-driven decision-making in a rapidly evolving landscape.
.png)
.png)